LOS ALTOS overnight.
RenovoRx announced acceptance for publication in an international peer-reviewed journal, The Oncologist. The manuscript is titled, “Treatment of Locally Advanced Pancreatic Cancer (LAPC) Using Localized Trans-Arterial Micro Perfusion (TAMP™) of Gemcitabine: Combined Analysis of RR1 and RR2” and expected in the Summer 2024 issue of The Oncologist.
End.
IMU, in collaboration with Renovo is waiting in line for its turn, not a matter of if but when.
RNXT up on the announcement.
IMO & pure speculation.
Media Thread, page-14587
-
- There are more pages in this discussion • 418 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
